JP Morgan Reiterates Neutral Rating on Brown & Brown, Inc. (BRO)
Rating Change JP Morgan analysts reiterated a Neutral rating on Brown & Brown, Inc. (NYSE:BRO) on August 03, 2026. Market Context Brown & Brown, Inc.
Read moreReal-time context
Upgrades, downgrades, initiations, and price-target changes.
Rating Change JP Morgan analysts reiterated a Neutral rating on Brown & Brown, Inc. (NYSE:BRO) on August 03, 2026. Market Context Brown & Brown, Inc.
Read moreRating Change Barclays analysts reiterated a Overweight rating on MicroStrategy Incorporated Variable Rate Series A Perpetual Stretch Preferred Stock (NASDAQ:STRC) on August 03,…
Read moreRating Change Cantor Fitzgerald analysts reiterated a Overweight rating on MicroStrategy Incorporated Variable Rate Series A Perpetual Stretch Preferred Stock (NASDAQ:STRC) on…
Read moreRating Change B. Riley Securities analysts reiterated a Buy rating on MicroStrategy Incorporated Variable Rate Series A Perpetual Stretch Preferred Stock (NASDAQ:STRC) on August…
Read moreRating Change Barclays analysts reiterated a Overweight rating on Mettler-Toledo International Inc. (NYSE:MTD) on August 03, 2026. Market Context Mettler-Toledo International Inc.
Read moreRating Change Stifel analysts reiterated a Buy rating on Mettler-Toledo International Inc. (NYSE:MTD) on August 03, 2026. Market Context Mettler-Toledo International Inc.
Read moreRating Change Wells Fargo analysts reiterated a Equal-Weight rating on Mettler-Toledo International Inc. (NYSE:MTD) on August 03, 2026. Market Context Mettler-Toledo International…
Read moreRating Change Evercore ISI Group analysts reiterated a Outperform rating on Mettler-Toledo International Inc. (NYSE:MTD) on August 03, 2026. Market Context Mettler-Toledo…
Read moreRating Change BMO Capital analysts reiterated a Outperform rating on LPL Financial Holdings Inc. (NASDAQ:LPLA) on August 03, 2026. Market Context LPL Financial Holdings Inc.
Read moreRating Change Leerink Partners analysts reiterated a Outperform rating on Keros Therapeutics, Inc. (NASDAQ:KROS) on August 04, 2026. Market Context Keros Therapeutics, Inc.
Read moreRating Change Baird analysts downgraded V2X, Inc. (NYSE:VVX) from Outperform to Neutral on August 04, 2026. Market Context V2X, Inc.
Read moreRating Change BTIG analysts reiterated a Buy rating on FTAI Aviation Ltd. (NASDAQ:FTAIP) on August 04, 2026. Market Context FTAI Aviation Ltd.
Read moreRating Change BTIG analysts reiterated a Buy rating on FTAI Aviation Ltd. (NASDAQ:FTAIO) on August 04, 2026. Market Context FTAI Aviation Ltd.
Read moreRating Change BTIG analysts reiterated a Buy rating on FTAI Aviation Ltd. (NASDAQ:FTAIN) on August 04, 2026. Market Context FTAI Aviation Ltd.
Read moreRating Change BTIG analysts reiterated a Buy rating on FTAI Aviation Ltd. (NASDAQ:FTAIM) on August 04, 2026. Market Context FTAI Aviation Ltd.
Read moreRating Change Barclays analysts reiterated a Equal-Weight rating on Cameco Corporation (NYSE:CCJ) on August 04, 2026. Market Context Cameco Corporation operates in the Energy…
Read moreRating Change Mizuho analysts reiterated a Outperform rating on Ameren Corporation (NYSE:AEE) on August 03, 2026. Market Context Ameren Corporation operates in the Utilities…
Read moreRating Change Citigroup analysts downgraded Willis Towers Watson Public Limited Company (NASDAQ:WTW) from Buy to Neutral on August 03, 2026. Market Context Willis Towers Watson…
Read moreRating Change Cantor Fitzgerald analysts reiterated a Neutral rating on Willis Towers Watson Public Limited Company (NASDAQ:WTW) on August 03, 2026. Market Context Willis Towers…
Read moreRating Change Goldman Sachs analysts reiterated a Buy rating on Willis Towers Watson Public Limited Company (NASDAQ:WTW) on August 03, 2026. Market Context Willis Towers Watson…
Read more